Although high dose of streptozocin severely impairs insulin secretion mimicking type 1 diabetes, low dose of streptozocin destroys some population of pancreatic beta cells and has been known to induce a mild impairment of insulin secretion, which is similar to the feature of the later stage of type 2 diabetes (13). This evidence concerns the gene INS and type 2 diabetes mellitus.